| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
33,620,000 |
| Market
Cap: |
108.26(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.295 - $6.09 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Aquestive Therapeutics is a pharmaceutical company. Co. is developing orally administered products to deliver various molecules using its proprietary technologies, PharmFilm®. Co.'s products within its central nervous system portfolio, focused on epilepsy, include: Sympazan®, an oral soluble film formulation of clobazam used for the treatment of seizures associated with a rare, intractable form of epilepsy known as Lennox-Gastaut syndrome; and Libervant™, a buccally, or inside of the cheek, administered soluble film formulation of diazepam, used as an alternative to device-dependent rescue therapies, available to patients with refractory epilepsy, which are a rectal gel and nasal sprays.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
158,668 |
| Total Buy Value |
$0 |
$0 |
$0 |
$151,571 |
| Total People Bought |
0 |
0 |
0 |
4 |
| Total Buy Transactions |
0 |
0 |
0 |
5 |
| Total Shares Sold |
75,000 |
75,000 |
75,000 |
75,000 |
| Total Sell Value |
$429,685 |
$429,685 |
$429,685 |
$429,685 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
2 |
2 |
2 |
2 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Marshall Ken W. |
SVP, Chief Commercial Officer |
• – – |
2023-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
150,000 |
|
- |
|
| Wargacki Stephen |
SVP, Research & Development |
• – – |
2023-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
135,000 |
161,956 |
|
- |
|
| Boyd Peter E. |
See Remark |
• – – |
2023-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
159,532 |
|
- |
|
| Braender Lori J |
SVP, General Counsel |
• – – |
2023-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
188,761 |
|
- |
|
| Toth A Ernest Jr |
SVP, Chief Financial Officer |
• – – |
2023-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
140,000 |
140,000 |
|
- |
|
| Jung Cassie |
SVP, Operations |
• – – |
2023-01-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,044 |
|
119% |
|
| Jung Cassie |
SVP, Operations |
• – – |
2023-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
36,747 |
|
119% |
|
| Wargacki Stephen |
SVP, Research & Development |
• – – |
2023-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
26,956 |
|
119% |
|
| Boyd Peter E. |
SVP-Bus. Process & Info. Tech. |
• – – |
2022-06-14 |
4 |
B |
$0.81 |
$4,050 |
D/D |
5,000 |
59,532 |
2.66 |
7% |
|
| Boyd Peter E. |
SVP-Bus. Process & Info. Tech. |
• – – |
2022-06-08 |
4 |
B |
$0.96 |
$2,201 |
D/D |
2,293 |
54,532 |
2.66 |
4% |
|
| Barber Daniel |
Chief Executive Officer |
• – – |
2022-06-08 |
4 |
B |
$0.96 |
$88,073 |
D/D |
91,743 |
193,702 |
2.74 |
4% |
|
| Braender Lori J |
General Counsel |
• – – |
2022-06-08 |
4 |
B |
$0.96 |
$13,211 |
D/D |
13,761 |
38,761 |
2.74 |
4% |
|
| Schobel Alexander Mark |
Chief Innovation/Tech Officer |
• – – |
2022-06-08 |
4 |
B |
$0.96 |
$44,036 |
D/D |
45,871 |
882,871 |
2.74 |
4% |
|
| Cochran John |
|
– • – |
2021-05-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
37,500 |
99,486 |
|
- |
|
| Bratton Capital Management, L.p. |
|
– – • |
2021-03-12 |
4 |
A |
$0.00 |
$0 |
I/I |
1,783,578 |
1,948,578 |
|
- |
|
| Bratton Capital Management, L.p. |
|
– – • |
2021-03-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,475,914) |
0 |
|
- |
|
| Cochran John |
|
– • – |
2021-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
61,901 |
136,986 |
|
- |
|
| Bratton Capital Management, L.p. |
|
– – • |
2021-03-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
62,500 |
12,585 |
|
- |
|
| Schobel Alexander Mark |
Chief Innovation/Tech Officer |
• – – |
2021-02-10 |
4 |
AS |
$6.75 |
$158,355 |
D/D |
(23,460) |
837,000 |
|
-38% |
|
| Schobel Alexander Mark |
Chief Innovation/Tech Officer |
• – – |
2021-02-09 |
4 |
AS |
$6.75 |
$77,895 |
D/D |
(11,540) |
860,460 |
|
-40% |
|
| Schobel Alexander Mark |
Chief Innovation/Tech Officer |
• – – |
2021-02-08 |
4 |
AS |
$6.50 |
$265,148 |
D/D |
(40,792) |
872,000 |
|
-38% |
|
| Maxwell John T. |
SVP-Chief Financial Officer |
• – – |
2020-08-18 |
4 |
AS |
$8.00 |
$24,000 |
D/D |
(3,000) |
150,614 |
|
-34% |
|
| Schobel Alexander Mark |
Chief Innovation/Tech Officer |
• – – |
2020-06-30 |
4 |
D |
$4.86 |
$457 |
D/D |
(94) |
912,792 |
|
- |
|
| Schobel Alexander Mark |
Chief Innovation/Tech Officer |
• – – |
2020-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
333 |
912,886 |
|
- |
|
| Kendall Keith J |
CEO and President |
• • – |
2020-06-30 |
4 |
D |
$4.86 |
$719 |
D/D |
(148) |
639,149 |
|
- |
|
146 Records found
|
|
Page 2 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.02 (0.63%) 
